(FOA)-Focused
Technology Research and Development (R01 - Clinical Trial Not Allowed); June 5,
2019
Agency
NIH
Description
This
initiative will support projects that focus solely on development of
technologies with the potential to enable acquisition of basic biomedical
knowledge. Projects should be justified in terms of technical innovation, and
utility for future biomedical impact. The products of this research will be
functioning prototype instruments, methods, synthetic approaches, biological
products, etc., characterized adequately to be ready for first application to
the type of biomedical research questions that provide the rationale for their
development, but application of the proposed technology to specific biomedical
questions is considered beyond the scope of the program, should not be included,
and would not be funded. Proof of principle for the technology will have already
been shown, but there will still be significant fundamental technical
challenges. Applications should include preliminary data. Projects that have
significant remaining risk but are supported by early feasibility studies might
be appropriate for a three year R01 proposal with reduced budget to better
manage risk and investment. Projects that are well supported by feasibility
studies and propose to develop fully functional prototypes might require higher
budgets and a four year duration (five years for early stage investigators).
Projects that primarily focus on optimization, hardening, or obvious
extrapolations of established technology might be less competitive.
Activity
Code
R01
Announcement
Number
PAR-19-253
Closing
Date
June
5, 2019
Link
to Full Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-19-253.html
Companion
Funding Opportunity
http://grants.nih.gov/grants/guide/pa-files/PAR-19-254.html